Abrogation of SHP-1 in tumor-specific effector T cells during adoptive immunotherapy of disseminated leukemia

被引：0
|
作者：
Stromnes, Ingunn [1 ]
Fowel, Carla [1 ]
Blattman, Joseph [1 ,2 ]
Tan, Xiaoxia [1 ]
Greenberg, Philip [1 ,2 ]
机构：
[1] Univ Washington, Immunol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
131.15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Stable expression of a retrovirally transferred adhesion molecule in a human tumor-specific CTL clone -: Perspectives for the ex vivo manipulation of effector cells used in adoptive immunotherapy
    Cochlovius, B
    Zawadzki, V
    Perschl, A
    Zöller, M
    GENE THERAPY OF CANCER, 1998, 451 : 345 - 348
  • [32] Expression of a CD200-targeted chimeric costimulatory receptor enhances T cell effector function and adoptive immunotherapy of disseminated leukemia
    Oda, S.
    Daman, A.
    Garcia, N.
    Tan, X.
    Greenberg, P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 593 - 593
  • [33] Expression of a CD200-targeted chimeric costimulatory receptor enhances T cell effector function and adoptive immunotherapy of disseminated leukemia
    Oda, Shannon K.
    Daman, Andrew W.
    Garcia, Nicolas M.
    Tan, Xiaoxia
    Greenberg, Philip D.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [34] In vitro system for generation of leukemia-specific cytotoxic T cells for adoptive immunotherapy.
    Ghosh, A
    Wolenski, M
    Klein, C
    Welte, K
    Blazar, BR
    Sauer, MG
    BLOOD, 2005, 106 (11) : 310A - 310A
  • [35] TREATMENT OF DISSEMINATED LEUKEMIA WITH CYCLOPHOSPHAMIDE AND IMMUNE CELLS - TUMOR-IMMUNITY REFLECTS LONG-TERM PERSISTENCE OF TUMOR-SPECIFIC DONOR T-CELLS
    GREENBERG, PD
    CHEEVER, MA
    JOURNAL OF IMMUNOLOGY, 1984, 133 (06): : 3401 - 3407
  • [36] Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy
    Yue Wang
    Shi-Kun Zhou
    Yan Wang
    Zi-Dong Lu
    Yue Zhang
    Cong-Fei Xu
    Jun Wang
    Nature Communications, 14
  • [37] Regulation and impact of tumor-specific CD4+T cells in cancer and immunotherapy
    Guo, Mengdi
    Liu, Melissa Yi Ran
    Brooks, David G.
    TRENDS IN IMMUNOLOGY, 2024, 45 (04) : 303 - 313
  • [38] Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy
    Wang, Yue
    Zhou, Shi-Kun
    Wang, Yan
    Lu, Zi-Dong
    Zhang, Yue
    Xu, Cong-Fei
    Wang, Jun
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [39] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
    Christian Blank
    Thomas F. Gajewski
    Andreas Mackensen
    Cancer Immunology, Immunotherapy, 2005, 54 : 307 - 314
  • [40] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
    Blank, C
    Gajewski, TF
    Mackensen, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) : 307 - 314
12345